Akebia Therapeutics (AKBA) Depreciation & Amortization (CF) (2013 - 2026)
Akebia Therapeutics (AKBA) posted Depreciation & Amortization (CF) of $585,000 for Q2 2026, up 85.1% from $316,000 a year earlier and up 78.4% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Akebia Therapeutics was $1.55 million, up 16.9% year-over-year; for FY2025, it came in at $1.27 million, down 13.2% from FY2024.
- Annual Depreciation & Amortization (CF) has declined for six consecutive years, with a five-year compound annual growth rate of -9.4% (FY2020 to FY2025).
- In prior years, Akebia Therapeutics' Depreciation & Amortization (CF) was $1.46 million in FY2024 (-7.8%), $1.59 million in FY2023 (-4.2%), $1.65 million in FY2022 (-14.2%) and $1.93 million in FY2021 (-7.1%).
- The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) since Q4 2019.
- On a year-over-year basis, Depreciation & Amortization (CF) increased in two of the last eight quarters, with growth averaging 1.9%.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2026, with growth of 85.1%; the weakest was Q2 2025, with a decline of 21.0%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $328,000 (Q1 2026), $321,000 (Q4 2025) and $318,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Akebia Therapeutics | 250.00 Mn | -419.48 Mn | 38.70 Mn | 585,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 585,000.00 |
| Mar 31, 2026 | 328,000.00 |
| Dec 31, 2025 | 321,000.00 |
| Sep 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 316,000.00 |
| Mar 31, 2025 | 314,000.00 |
| Dec 31, 2024 | 335,000.00 |
| Sep 30, 2024 | 363,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 364,000.00 |
| Dec 31, 2023 | 394,000.00 |
| Sep 30, 2023 | 396,000.00 |
| Jun 30, 2023 | 397,000.00 |
| Mar 31, 2023 | 398,000.00 |
| Dec 31, 2022 | 408,000.00 |
| Sep 30, 2022 | 413,000.00 |
| Jun 30, 2022 | 416,000.00 |
| Mar 31, 2022 | 417,000.00 |
| Dec 31, 2021 | 442,000.00 |
| Sep 30, 2021 | 473,000.00 |
API Access
Akebia Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();